Related Experiment Video
Updated: Jun 8, 2026
07:30
Learning Modern Laryngeal Surgery in a Dissection Laboratory
Published on: March 18, 2020
Radiotherapy for laryngeal squamous cell carcinoma: current standards
Piet Dirix1, Maarten Lambrecht, Sandra Nuyts
1Department of Radiation Oncology, Leuvens Kankerinstituut (LKI), University Hospitals Leuven, Campus Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. piet.dirix@uz.kuleuven.be
Expert Review of Anticancer Therapy
|September 15, 2010
Summary
Advances in combined modality therapy and radiotherapy have significantly improved laryngeal cancer treatment outcomes. Larynx preservation is now achievable for most patients, enhancing survival rates for advanced disease.
Area of Science:
- Oncology
- Otolaryngology
- Radiation Oncology
Background:
- Laryngeal cancer treatment has evolved significantly over recent decades.
- Novel therapeutic strategies and improved radiotherapy techniques have emerged.
- Locoregionally advanced laryngeal cancer previously had high recurrence and mortality rates.
Purpose of the Study:
- To provide an overview of current laryngeal cancer treatment approaches.
- To contextualize the various treatment options for advanced disease.
- To guide clinicians in selecting optimal therapeutic regimens.
Main Methods:
- Review of combined modality therapy in laryngeal cancer.
- Analysis of advancements in radiotherapeutic techniques.
- Discussion of multimodality treatment protocols.
Main Results:
- Combined modality therapy and improved radiotherapy have increased long-term disease-free survival for advanced laryngeal cancer.
- Larynx preservation is now feasible in the majority of patients undergoing multimodality treatment.
- Significant improvements in managing locoregionally advanced disease have been observed.
Conclusions:
- Modern treatment strategies have substantially improved outcomes for laryngeal cancer patients.
- Multimodality treatment offers a high chance of larynx preservation and long-term survival.
- A clear perspective on varied treatment options is crucial for effective clinical decision-making.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...